Skip to main content
Logo
European Innovation Council
private sector

GrayMatters Health LTD

GrayMatters Health develops digital self-neuromodulation therapies for mental disorders. 

Overview

Description

GrayMatters Health develops digital self-neuromodulation therapies for mental disorders. They are the first to use advanced statistical models to develop biomarkers of brain-mechanism-specific activity associated with mental disorders. The company’s products use these biomarkers with an interactive audio/visual interface to help patients regain control over the relevant brain activity.

Website
Invested amount

EUR 2 000 000

Founded

2019

Project
Country
  • Israel
Theme
  • Health